Publisher Correction: The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M

Detalles Bibliográficos
Autores principales: Huang, Yen-Hsiang, Tseng, Jeng-Sen, Hsu, Kuo-Hsuan, Chen, Kun-Chieh, Su, Kang-Yi, Yu, Sung-Liang, Chen, Jeremy J. W., Yang, Tsung-Ying, Chang, Gee-Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Publisher Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405629/
https://www.ncbi.nlm.nih.gov/pubmed/34462521
http://dx.doi.org/10.1038/s41598-021-97248-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405629/
https://www.ncbi.nlm.nih.gov/pubmed/34462521
http://dx.doi.org/10.1038/s41598-021-97248-w

Ejemplares similares